Ironwood Pharma (IRWD) Tops Q3 EPS by 29c

Ironwood Pharma (NASDAQ: IRWD) reported Q3 EPS of $0.42, $0.29 better than the analyst estimate of $0.13. Revenue for the quarter came in at $96.4 million versus the consensus estimate of $75.9 million.

For earnings history and earnings-related data on Ironwood Pharma (IRWD) click here.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Nvidia pitches Vera CPU to Chinese clients with August delivery target
• Medtronic completes $550 million Scientia Vascular acquisition
• 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO